Skip to Main Content

Author Details

Robert H Bell
University of British Columbia
2004
43
24
PMIDPaper TitleJournal TitlePublished Year
36181708Indwelling stents cause obstruction and induce ureteral injury and fibrosis in a porcine model.BJU Int2023
37015949Indwelling stents cause severe inflammation and fibrosis of the ureter via urothelial-mesenchymal transition.Sci Rep2023
36611121Chaperone-mediated autophagy promotes PCa survival during ARPI through selective proteome remodeling.Oncogene2023
33441310Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.Cancer Res2021
34192572Cobalt ions induce metabolic stress in synovial fibroblasts and secretion of cytokines/chemokines that may be diagnostic markers for adverse local tissue reactions to hip implants.Acta Biomater2021
33158661Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors.Eur Urol2021
32406909G3BP1-linked mRNA partitioning supports selective protein synthesis in response to oxidative stress.Nucleic Acids Res2020
32029828Identification of gene signature for treatment response to guide precision oncology in clear-cell renal cell carcinoma.Sci Rep2020
30590461Modeling human prostate cancer progression in vitro.Carcinogenesis2019
30777011Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer.BMC Genomics2019
30351359Alignment-free clustering of UMI tagged DNA molecules.Bioinformatics2019
28927585Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression.Eur Urol2018
29905005Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer.Cancer Med2018
28330676Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.Eur Urol2018
29116394A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer.World J Urol2018
27531099SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.Bioinformatics2017
28259916Notch signaling is significantly suppressed in basal cell carcinomas and activation induces basal cell carcinoma cell apoptosis.Mol Med Rep2017
28460430Metabolic heterogeneity signature of primary treatment-naïve prostate cancer.Oncotarget2017
28266173Adverse reactions to metal on polyethylene implants: Highly destructive lesions related to elevated concentration of cobalt and chromium in synovial fluid.J Biomed Mater Res A2017
28516513Evaluating an educational intervention to alleviate distress amongst men with newly diagnosed prostate cancer and their partners.BJU Int2017
27015368The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells.Oncotarget2016
27262395Differences in Overall and Cancer-specific Survival of Patients Presenting With Chromophobe Versus Clear Cell Renal Cell Carcinoma: A Propensity Score Matched Analysis.Urology2016
25544761Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer.Oncotarget2015
26235627The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.Cell Rep2015
25712683Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer.Clin Cancer Res2015
25596645Bcl-2 predicts response to neoadjuvant chemotherapy and is overexpressed in lymph node metastases of urothelial cancer of the bladder.Urol Oncol2015
24318647Suppression of lipopolysaccharide-stimulated cytokine/chemokine production in skin cells by sandalwood oils and purified α-santalol and β-santalol.Phytother Res2014
25155515Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.Genome Biol2014
24356420High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development.Cancer Res2014
23041343A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy.J Urol2013
23464844Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.BJU Int2013
23500642Hiding in plain view: genetic profiling reveals decades old cross contamination of bladder cancer cell line KU7 with HeLa.J Urol2013
22294438Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer.J Pathol2012
22553170From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer.J Pathol2012
22615732Deficiency in nucleotide excision repair family gene activity, especially ERCC3, is associated with non-pigmented hair fiber growth.PLoS One2012
22252602Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.Mol Cancer Ther2012
21388585Radical prostatectomy for high-risk clinically localized prostate cancer: a prospective single institution series.Can Urol Assoc J2011
19932600Lichen planopilaris and pseudopelade of Brocq involve distinct disease associated gene expression patterns by microarray.J Dermatol Sci2010
20392586Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T--quantitative correlation with biopsy.Magn Reson Imaging2010
18785179Insulin receptor expression by human prostate cancers.Prostate2009
18200053Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles.J Invest Dermatol2008
16997353Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumors.Hum Pathol2007
15574769Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model.Cancer Res2004
  • 1 - 43 of 43

Recommended Authors

Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 6
Travis Gerke
The Prostate Cancer Clinical Trials Consortium
Career Start Year 2014
Number of shared co-authors 13
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 14
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 10
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 5
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 22
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 10
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2003
Number of shared co-authors 5
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 25
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 14
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 8
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 25
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 3
H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1999
Number of shared co-authors 10
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 9
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 16
Robert Kim
University of California
Career Start Year 1996
Number of shared co-authors 11
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Career Start Year 1995
Number of shared co-authors 27
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 7
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 13
Peter S Nelson
Fred Hutchinson Cancer Center
Career Start Year 1993
Number of shared co-authors 29
Isla P Garraway
David Geffen School of Medicine University of California Los Angeles
Career Start Year 1993
Number of shared co-authors 15
Rosina T Lis
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 12
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 5
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 9
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 17
Beatrice S Knudsen
University of Utah
Career Start Year 1986
Number of shared co-authors 19
Dominique Trudel
Institut du cancer de Montreal
Career Start Year 1985
Number of shared co-authors 9
Massimo Loda
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 21
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 16

Collaborators

Martin E Gleave
University of British Columbia
Co-authored papers 20
Colin C Collins
University of British Columbia
Co-authored papers 19
Anne Haegert
University of British Columbia
Co-authored papers 19
Stanislav V Volik
University of British Columbia
Co-authored papers 12
Yuzhuo Wang
University of British Columbia
Co-authored papers 11
Ladan Fazli
University of British Columbia
Co-authored papers 11
Shawn Anderson
University of British Columbia
Co-authored papers 10
Sonal Brahmbhatt
University of British Columbia
Co-authored papers 9
Antonio Hurtado-Coll
University of British Columbia
Co-authored papers 9
Fan Mo
Institute of Stem Cell and Regeneration, Chinese Academy of Sciences
Co-authored papers 8
Alexander W Wyatt
University of British Columbia
Co-authored papers 8
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Co-authored papers 7
Brian McConeghy
University of British Columbia
Co-authored papers 7
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Co-authored papers 7
Faraz Hach
University of British Columbia
Co-authored papers 5
Anna Lapuk
Contextual Genomics Inc.
Co-authored papers 4
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 4
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 4
Suleyman Cenk Sahinalp
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Mark A Rubin
University of Bern
Co-authored papers 4
Robert Shukin
University of British Columbia
Co-authored papers 4
Raunak Shrestha
University of California San Francisco
Co-authored papers 3
Edward C Jones
University of British Columbia
Co-authored papers 3
Andrew McPherson
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Shancheng Ren
Shanghai Changzheng Hospital
Co-authored papers 3
Christopher A Maher
Washington University in St Louis
Co-authored papers 3
Marco A Marra
University of British Columbia
Co-authored papers 3
Kim N Chi
University of British Columbia
Co-authored papers 3
Chunxiao Wu
Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University
Co-authored papers 3
Martin Hirst
University of British Columbia
Co-authored papers 2
Release 1.2